Patient Testimonial: Patty – Cancer Signal Detected

Even with regular mammograms and colonoscopies, Patty knew some cancers could still hide. So when she learned her company was offering the Galleri multi-cancer early detection (MCED) test as an employee health benefit, she decided to give it a try - despite being asymptomatic. Watch as she shares how the Galleri test helped lead to a diagnosis and treatment for large B-cell non-Hodgkin’s lymphoma. Learn more about Galleri: https://grail.com https://galleri.com Galleri should be used in addition to healthcare provider recommended screening tests. The Galleri test does not detect a signal for all cancers and not all cancers can be detected in the blood. False positive and false negative results do occur. Galleri is a screening test and does not diagnose cancer. Diagnostic testing is needed to confirm cancer. Based on a clinical study of people ages 50 to 79, around 1% are expected to receive a “Cancer Signal Detected” result. After diagnostic evaluation, around 62% of these people are expected to have a confirmed cancer diagnosis. The overall sensitivity in study participants with lymphoma was 56.3% (27.3% for stage I, 58.3% stage II, 71.7% stage III, 60.9% stage IV). Rx only. See Important Safety Information: http://bit.ly/33m8pFa